RO7046015, RO7046015
BP39529
Phase 2 small_molecule active
Quick answer
RO7046015, RO7046015 for Early Idiopathic Parkinson’s disease (PD) is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Early Idiopathic Parkinson’s disease (PD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active